Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
LINCOLN

Lincoln Pharmaceuticals Share Price

 

 

Lincoln Pharmaceuticals live price: ₹608.15. It opened at ₹625 vs previous close ₹616; intraday high/low: ₹635/₹603. The 50 & 200 DMA stand at ₹576.39/₹556.29.

Lincoln Pharmaceuticals Performance

  • Today's Low
  • ₹603
  • Today's High
  • ₹635
  • 52 Week Low
  • ₹440
  • 52 Week High
  • ₹677
  • Open Price₹625
  • Previous Close₹616
  • Volume58,977
  • 50 DMA₹576.39
  • 100 DMA₹558.44
  • 200 DMA₹556.29

Lincoln Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 1.29%
  • Over 3 Month + 31.91%
  • Over 6 Month + 16.19%
  • Over 1 Year + 7.57%

Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!

Invest Now

Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.9
  • PEG Ratio
  • -8.1
  • Market Cap Cr
  • 1,218
  • P/B Ratio
  • 1.6
  • Average True Range
  • 26.95
  • EPS
  • 43.85
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -0.86
  • RSI
  • 56.34
  • MFI
  • 68.19

Lincoln Pharmaceuticals Financials

Lincoln Pharmaceuticals Technicals

EMA & SMA

Current Price
₹608.15
-7.9 (-1.28%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹588.51
  • 50 Day
  • ₹576.39
  • 100 Day
  • ₹558.44
  • 200 Day
  • ₹556.29

Resistance and Support

615.25 Pivot Speed
  • R3 658.80
  • R2 646.65
  • R1 627.40
  • S1 596.00
  • S2 583.85
  • S3 564.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lincoln Pharmaceuticals manufactures pharmaceutical formulations across various therapeutic segments, including antibiotics, anti-malarial, and nutraceuticals. With state-of-the-art production facilities, it serves domestic and international markets, exporting products to over 60 countries globally.

Lincoln Pharmaceuticals has an operating revenue of Rs. 651.94 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 18% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 14% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 60 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-07 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-02-13 Quarterly Results
Date Purpose Remarks
2025-09-12 FINAL Rs.1.80 per share(18%)Final Dividend
View Lincoln Pharmaceuticals Dividend History Arrow

Lincoln Pharmaceuticals F&O

Lincoln Pharmaceuticals Shareholding Pattern

49.78%
0%
5.2%
34.7%
10.32%

Lincoln Pharmaceuticals FAQs

Lincoln Pharmaceuticals share price is ₹608 As on 22 April, 2026 | 00:58

The Market Cap of Lincoln Pharmaceuticals is ₹1218.1 Cr As on 22 April, 2026 | 00:58

The P/E ratio of Lincoln Pharmaceuticals is 13.9 As on 22 April, 2026 | 00:58

The PB ratio of Lincoln Pharmaceuticals is 1.6 As on 22 April, 2026 | 00:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23